Industries > Pharma > Influenza Vaccines Market Report 2020-2030
Influenza Vaccines Market Report 2020-2030
Forecasts by Vaccine Type (Quadrivalent, Trivalent), by End-users (Hospitals, Specialty Clinics, Other End-Users), by Country, by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Profiles of Leading Influenza Vaccines Companies PLUS EXCLUSIVE COVID-19 Recovery Scenarios
Influenza vaccines set to witness steady growth over next 10 years
Vaccines are essential NOW. We all understand the race for a COVID-19 vaccine – however with health services strained, budgets stretched, the critical creation, supply and delivery of flu vaccines globally has never been more important. No nation can afford a double hit.
This report tells you TODAY how flu vaccines will develop in the next 10 years, and in-line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Discover how to stay ahead
Our exclusive 280+ page report provides 350+ tables and charts/graphs. Discover the most lucrative areas within flu vaccines and the short and long term future prospects. Our new study forecasts sales at overall world, regional and national level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Influenza Vaccines Market. See how to exploit the opportunities and succeed today.
If you only read one Flu Report this year – it must be this report. Only a small number of these reports are available.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
The emergence of a Universal Flu Vaccine
The influenza vaccine market is constantly thriving to improve vaccine efficiency and provide better protection each season. Is this possible? Pharma companies tackle novel approaches to vaccine technology, better administration and delivery, plus production of the vaccine. Never has this been more critical – yet never before has it offered you such opportunity for development.
Forecasts to 2030 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares of your main competitors.
• Original analyses – this is not available anywhere else
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), SWOT Analysis, product profiles and commercial developments.
UNIQUE COVID-19 VARIATIONS – only available in this Visiongain report are dedicated analysis of 4 different rebound scenarios of how the market will develop – no matter how COVID-19 effects the economy.
Discover sales predictions for the world market and submarkets
By Vaccine Type
• Quadrivalent
• Trivalent
By End-Users
• Hospitals
• Specialty Clinics
• Other End-Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:
By Region
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East & Africa
• GCC
• South Africa
• Rest of Middle East & Africa
Need industry data? Please contact us today.
Leading companies and the potential for market growth
Overall world revenue for Influenza Vaccines Market will surpass $xx million in 2020, our work calculates. We predict strong revenue growth through to 2030. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Influenza Vaccines Market report helps you
In summary, our 280+ page report provides you with the following knowledge:
• Revenue forecasts to 2030 for Influenza Vaccines Market, with forecasts for Vaccine Type and End User, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2030 for 5 regional and 14 key national markets – See forecasts for the Influenza Vaccines market in North America, Europe, Asia-Pacific and Rest of the World. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, and Japan, among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for 10 of the major companies involved in the Influenza Vaccines Market. Some of the companies profiled in this report include Biodiem, CSL Limited, Emergent BioSolutions, AstraZeneca, Merck & Co., Inc., Novartis AG, Sanofi, F. Hoffmann-La Roche Ltd., Sinovac Biotech Ltd., Mitsubishi Tanabe Pharma Corporation, and Takeda Pharmaceutical Company Limited.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Influenza Vaccines Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Influenza Vaccines Market Report 2020-2030: Forecasts by Vaccine Type (Quadrivalent, Trivalent), by End-users (Hospitals, Specialty Clinics, Other End-Users), by Country, by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) and Profiles of Leading Influenza Vaccines Companies PLUS EXCLUSIVE COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Global Influenza Vaccines Market Segmentation
1.1 Why You Should Read This Report
1.2 What This Report Delivers
1.3 Key Questions Answered By This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.5.1 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQs)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2 Introduction
2.1 What is Influenza
2.2 Bird Flu
2.2.1 The avian influenza virus causes bird flu. Birds can be infected by influenza A viruses and all of its subtypes.
2.3 Annual Epidemics
2.3.1 Every year influenza causes 3-5 million cases of severe illness
2.4 Social & Economic Burden
2.4.1 An estimated $17 billion in the US alone is spent on direct medical costs and loss of labor on adults who have contracted influenza
3 Influenza Vaccine by Technology
3.1 Egg Based Flu Vaccine
3.1.1 The egg-based production system is used to make almost 500 million doses of flu vaccine every year.
3.2 Cell-Based Flu Vaccines
3.2.1 FDA issued an approval for Seqirus, the sole FDA-approved cell-based flu vaccine manufacturer in the United States, to use cell-grown CVVs.
3.3 Recombinant Flu Vaccines
3.3.1 This process can produce vaccine in the shortest amount of time
4 Executive Summary
4.1 Trivalent vaccine type anticipated to hold ~US$ 3.6 billion revenue in 2020
4.2 Quadrivalent to witness a CAGR of over 8%
4.3 Asia Pacific to witness the highest CAGR of over ~6%
5 Global Influenza Vaccines Market Overview
5.1 Drivers
5.1.1 Growing Elderly Population: Influenza vaccinations account for 50% of the demand for elderly people over 65 years
5.1.2 Growing Investments in Vaccine Development: Strong impetus for vaccine manufacturers to renew and/or expand research efforts
5.1.3 High Prevalence of Infectious Diseases: High prevalence of diseases, such as cholera, tuberculosis, hepatitis, and malaria will ensure strong demand for associated vaccines
5.1.4 Rising R&D Activities: Rising prevalence of infectious diseases and the growing focus on the immunization programs are considered as the major factors that are projected to enhance the growth
5.1.5 Increase in Government Focus on Immunization Programs: Broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs
5.1.6 Paediatric Influenza Vaccines: Paediatric influenza vaccines make up the second largest share of this vaccine industry
5.2 Restraints
5.2.1 Inadequate Reimbursement Coverage: National Immunization Survey found that 79% of privately insured children had some sort of payment associated with their last immunization visit.
5.2.2 Longer timelines required for Vaccine Production: Vaccine development is a long, complex process, often lasting 10-15 years
5.3 Opportunities
5.3.1 Rising Demand from Emerging Economies: China and India have already implemented the influenza vaccine into their immunization programmes
5.4 Market Trends
5.4.1 Demand Driven Trends: Developing economies are increasingly looking to improve their healthcare systems
5.4.2 Funding Trends: Despite the trend of increasing demand and supply in the future for the influenza vaccines market, funding is another factor that will affect the growth of the market
5.4.3 Protecting Workforce: Influenza results in hospitalization of up to 200,000 people each year. Such healthcare costs and burden have forced the governments to recognize the severity of influenza as a serious infection
5.5 SWOT Analysis
5.5.1 Strengths
5.5.1.1 Ageing Population
5.5.1.2 Influenza Prevention is Crucial
5.5.1.3 Growing Emerging Economies
5.5.1.4 Rising Disease Awareness
5.5.2 Weaknesses
5.5.2.1 Supply Chain Costs
5.5.2.2 Time Constraints
5.5.2.3 Barriers to Entry
5.5.2.4 Storage and Handling of Influenza Vaccines
5.5.3 Opportunities
5.5.3.1 Strong R&D Pipeline
5.5.3.2 Innovations and Technological Advancements
5.5.3.3 Universal Flu Vaccine
5.5.3.4 Adult Vaccines
5.5.4 Threats
5.5.4.1 Productivity Gap
5.6 PEST Analysis
5.6.1 Political Factors
5.6.1.1 Influence of Governments: The economic issues are very closely linked to the political issues that could influence the influenza vaccines market
5.6.2 Economic Factors
5.6.2.1 Cost & Time: Cost is a big factor in most things, and the influenza vaccines industry is no exception
5.6.2.2 Emerging Economies: High needs for preventive medicine across emerging economies to boost market growth
5.6.3 Social Factors
5.6.3.1 Creating a Healthier Society: One of the biggest social factors of the influenza vaccines industry would be the obvious benefits to healthcare that they bring
5.6.3.2 Public Fears of Side-Effects: On the flip side of the health benefits that vaccines bring, we can see slight resistance to vaccines from some
5.6.4 Technological Factors
5.6.4.1 Advancements in Vaccine Technology: Advancements being made in the influenza vaccine development will play a part in the future of the business
5.7 R&D Landscape Analysis
5.7.1 Fluzone® QIV HD: Fluzone High-Dose Quadrivalent is approved for use in persons 65 years of age and older.
5.7.2 AFLURIA® Quad (Quadrivalent Egg-based Influenza Vaccine): Afluria Quad™ is an inactivated quadrivalent influenza vaccine indicated for use in adults aged 18 years and over.
5.7.3 FLUCELVAX®: FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older.
5.7.4 FLUAD®: FLUAD is approved in over 30 countries; and to date, more than 81 million FLUAD doses have been distributed worldwide.
5.7.5 UNI-FLU: This candidate is a nanoparticle vaccine that self-assembles during production and that displays a cross-reactive antigen for each broad influenza group
5.7.6 NanoFlu™
6 Market Comparison Developed V.S. Emerging Economies
6.1 Developed Economies
6.2 Emerging Economies
6.3 Influenza Vaccine Situation Across LMIC Region
6.3.1 Egypt: Vaccination coverage remains low in Egypt
6.3.2 Lebanon: Uptake of the vaccines is improving; it is still a long way to achieve full coverage of high-risk vaccines.
6.3.3 Saudi Arabia: There have also been several public awareness campaigns the flu vaccine is administered and funded by MoH.
7 Global Influenza Vaccines Market Size Forecast 2020-2030 by Vaccine Type
7.1 Global Influenza Vaccines Market for Quadrivalent Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2 Global Influenza Vaccines Market for Trivalent Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8 Global Influenza Vaccines Market Size Forecast 2020-2030 by End-Users
8.1 Global Influenza Vaccines Market for Hospitals Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2 Global Influenza Vaccines Market for Specialty clinics segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3 Global Influenza Vaccines Market for Other End-Users Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9 Regional and Leading National Influenza Vaccines Market Forecasts 2020-2030
9.1 Global Influenza Vaccines Market by National Market Forecast 2020-2030
9.1.1 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.2 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.3 "W" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.4 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10 North America
10.1 North America Influenza Vaccines Market by Country Forecast 2020-2030
10.2 North America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
10.2.1 Recovery Scenarios (V, U, W, L): North America Influenza Vaccines Market by Vaccine Type
10.3 North America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
10.3.1 Recovery Scenarios (V, U, W, L): North America Influenza Vaccines Market by End-Users
10.4 U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.1 Obama Healthcare Reform – the Benefits for Vaccine Sales
10.4.2 In the US Influenza Vaccines Come Equally from Manufacturers and Distributors
10.4.3 “V” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.4 “U” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.5 “W” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.6 “L” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.5 Canada Influenza Vaccines Market Forecast 2020-2030
10.5.1 High Burden Among Children Population
10.5.2 Vaccine Products Available for Use in Canada
10.5.3 “V” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.4 “U” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.5 “W” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.6 “L” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
11 Europe
11.1 Europe Influenza Vaccines Market by Country Forecast 2020-2030
11.2 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
11.2.1 Recovery Scenarios (V, U, W, L): Europe Influenza Vaccines Market by Vaccine Type
11.3 Europe Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
11.3.1 Recovery Scenarios (V, U, W, L): Europe Influenza Vaccines Market by End-Users
11.4 Germany Influenza Vaccines Market Forecast 2020-2030
11.4.1 Economic Downturn and Ripple Effect
11.4.2 “V” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.3 “U” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.4 “W” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.5 “L” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.5 France Influenza Vaccines Market Forecast 2020-2030
11.5.1 Prominent Market
11.5.2 French Healthcare System
11.5.3 Doubt over Vaccine Safety Among French Population
11.5.4 “V” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.5 “U” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.6 “W” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.7 “L” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.6 UK Influenza Vaccines Market Forecast 2020-2030
11.6.1 Mature Market
11.6.2 “V” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.3 “U” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.4 “W” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.5 “L” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.7 Italy Influenza Vaccines Market Forecast 2020-2030
11.7.1 Economic Climate
11.7.2 Challenges in Public Healthcare
11.7.3 “V” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.4 “U” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.5 “W” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.6 “L” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.8 Spain Influenza Vaccines Market Forecast 2020-2030
11.8.1 Ageing Population
11.8.2 Economic Challenges
11.8.3 “V” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.4 “U” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.5 “W” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.6 “L” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.9 Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.1 “V” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.2 “U” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.3 “W” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.4 “L” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
12 Asia Pacific
12.1 Asia Pacific Influenza Vaccines Market by Country Forecast 2020-2030
12.2 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
12.2.1 Recovery Scenarios (V, U, W, L): Asia Pacific Influenza Vaccines Market by Vaccine Type
12.3 Asia Pacific Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
12.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Influenza Vaccines Market by End-Users
12.4 Japan Influenza Vaccines Market Forecast 2020-2030
12.4.1 Challenging Market
12.4.2 Vaccine Gap to Offer Immense Growth Opportunities
12.4.3 “V” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.4 “U” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.5 “W” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.6 “L” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.5 China Influenza Vaccines Market Forecast 2020-2030
12.5.1 Growing Population
12.5.2 Growing National Demand
12.5.3 Low Confidence Towards Domestic Vaccine
12.5.4 Voluntarily Spending by Chinese Population
12.5.5 “V” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.6 “U” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.7 “W” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.8 “L” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.6 India Influenza Vaccines Market Forecast 2020-2030
12.6.1 Emerging Market
12.6.2 “V” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.3 “U” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.4 “W” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.5 “L” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.7 Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.1 “V” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.2 “U” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.3 “W” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.4 “L” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
13 Latin America
13.1 Latin America Influenza Vaccines Market by Country Forecast 2020-2030
13.2 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
13.2.1 Recovery Scenarios (V, U, W, L): Latin America Influenza Vaccines Market by Vaccine Type
13.3 Latin America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
13.3.1 Recovery Scenarios (V, U, W, L): Latin America Influenza Vaccines Market by End-Users
13.4 Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.1 “V” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.2 “U” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.3 “W” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.4 “L” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.5 Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.1 “V” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.2 “U” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.3 “W” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.4 “L” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.6 Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.1 “V” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.2 “U” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.3 “W” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.4 “L” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
14 Middle East and Africa
14.1 Middle East and Africa Influenza Vaccines Market by Country Forecast 2020-2030
14.2 Middle East and Africa Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
14.2.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Influenza Vaccines Market by Vaccine Type
14.3 Middle East and Africa Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
14.3.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Influenza Vaccines Market by End-Users
14.4 GCC Influenza Vaccines Market Forecast 2020-2030
14.4.1 “V” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.2 “U” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.3 “W” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.4 “L” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.5 South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.1 “V” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.2 “U” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.3 “W” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.4 “L” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.6 Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.1 “V” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.2 “U” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.3 “W” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.4 “L” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
15 Company Profiling
15.1 Biodiem
15.1.1 Biodiem: Company Snapshot
15.1.2 Biodiem: Company Overview
15.1.3 Biodiem: Financial Analysis
15.1.3.1 Net Revenue, 2015-2019
15.1.4 Biodiem: Products
15.1.5 Biodiem: Recent Developments
15.2 CSL Limited
15.2.1 CSL Limited: Company Snapshot
15.2.2 CSL Limited: Company Overview
15.2.3 CSL Limited: Financial Analysis
15.2.3.1 Net Revenue, 2015-2019
15.2.3.2 Gross Profit, 2015-2019
15.2.4 CSL Limited: Products
15.2.5 CSL Limited: Recent Developments
15.3 Emergent BioSolutions
15.3.1 Emergent BioSolutions: Company Snapshot
15.3.2 Emergent BioSolutions: Company Overview
15.3.3 Emergent BioSolutions: Financial Analysis
15.3.3.1 Net Revenue, 2015-2019
15.3.3.2 EBIDTA, 2015-2019
15.3.3.3 Gross Profit, 2015-2019
15.3.4 Emergent BioSolutions: Products
15.3.5 Emergent BioSolutions: Recent Developments
15.4 AstraZeneca
15.4.1 AstraZeneca: Company Snapshot
15.4.2 AstraZeneca: Company Overview
15.4.3 AstraZeneca: Financial Analysis
15.4.3.1 Net Revenue, 2015-2019
15.4.3.2 EBIDTA, 2015-2019
15.4.3.3 Gross Profit, 2015-2019
15.5 Merck & Co., Inc.
15.5.1 Merck & Co., Inc.: Company Snapshot
15.5.2 Merck & Co., Inc.: Company Overview
15.5.3 Merck & Co., Inc.: Financial Analysis
15.5.3.1 Net Revenue, 2015-2019
15.5.3.2 EBIDTA, 2015-2019
15.5.3.3 Gross Profit, 2015-2019
15.5.4 Merck & Co., Inc.: Recent Developments
15.6 Sanofi
15.6.1 Sanofi: Company Snapshot
15.6.2 Sanofi: Company Overview
15.6.3 Sanofi: Financial Analysis
15.6.3.1 Net Revenue, 2015-2019
15.6.3.2 EBIDTA, 2015-2019
15.6.3.3 Gross Profit, 2015-2019
15.6.4 Sanofi: Products
15.6.5 Sanofi: Recent Developments
15.7 F. Hoffmann-La Roche Ltd.
15.7.1 F. Hoffmann-La Roche Ltd.: Company Snapshot
15.7.2 F. Hoffmann-La Roche Ltd.: Company Overview
15.7.3 F. Hoffmann-La Roche Ltd.: Financial Analysis
15.7.3.1 Net Revenue, 2015-2019
15.7.3.2 EBIDTA, 2015-2019
15.7.3.3 Gross Profit, 2015-2019
15.7.4 F. Hoffmann-La Roche Ltd.: Recent Developments
15.8 Sinovac Biotech Ltd.
15.8.1 Sinovac Biotech Ltd.: Company Snapshot
15.8.2 Sinovac Biotech Ltd.: Company Overview
15.8.3 Sinovac Biotech Ltd.: Financial Analysis
15.8.3.1 Net Revenue, 2015-2019
15.8.3.2 EBIDTA, 2015-2019
15.8.3.3 Gross Profit, 2015-2019
15.8.4 Sinovac Biotech Ltd.: Recent Developments
15.9 Mitsubishi Tanabe Pharma Corporation
15.9.1 Mitsubishi Tanabe Pharma Corporation: Company Snapshot
15.9.2 Mitsubishi Tanabe Pharma Corporation: Company Overview
15.9.3 Mitsubishi Tanabe Pharma Corporation: Financial Analysis
15.9.3.1 Net Revenue, 2016-2018
15.9.4 Mitsubishi Tanabe Pharma Corporation: Recent Developments
15.10 Takeda Pharmaceutical Company Limited
15.10.1 Takeda Pharmaceutical Company Limited: Company Snapshot
15.10.2 Takeda Pharmaceutical Company Limited: Company Overview
15.10.3 Takeda Pharmaceutical Company Limited: Financial Analysis
15.10.3.1 Net Revenue, 2015-2019
15.10.3.2 EBIDTA, 2015-2019
15.10.3.3 Gross Profit, 2015-2019
16 Conclusion & Recommendations
16.1 Concluding Remarks
16.2 Prevention of Influenza by Use of Flu Shots Rises in Importance
16.3 Emergence of a Universal Flu Vaccine
16.4 Unique & Complex Market
16.5 Unmet Needs & Required Innovations
List of Tables
Table 1 Global Influenza Vaccines Market Snapshot, 2020 & 2030 (US$ million, CAGR %)
Table 2 Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 3 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 4 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 5 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 6 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 7 Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 8 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 9 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 10 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 11 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 12 Global Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 13 Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 14 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 15 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 16 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 17 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 18 Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 19 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 20 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 21 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 22 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 23 Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 24 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 25 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 26 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 27 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 28 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 29 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 30 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 31 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 32 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 33 North America Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 34 North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 39 North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 40 “V” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 41 “U” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 42 “W” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 43 “L” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 44 U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 45 "V" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 46 "U" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 47 “W” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 48 "L" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 49 Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 50 "V" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 51 "U" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 52 “W” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 53 "L" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 54 Europe Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 55 Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 56 “V” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 60 Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 61 “V” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 62 “U” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 63 “W” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 64 “L” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 65 Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 66 "V" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 67 "U" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 68 “W” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 69 "L" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 70 France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 71 "V" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 72 "U" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 73 “W” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 74 "L" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 75 UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 76 "V" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 77 "U" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 78 “W” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 79 "L" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 80 Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 81 "V" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 82 "U" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 83 “W” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 84 "L" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 85 Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 86 "V" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 87 "U" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 88 “W” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 89 "L" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 90 Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 91 "V" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 92 "U" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 93 “W” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 94 "L" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 95 Asia Pacific Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 96 Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 97 “V” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 98 “U” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 99 “W” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 100 “L” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 101 Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 102 “V” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 103 “U” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 104 “W” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 105 “L” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 106 Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 107 "V" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 108 "U" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 109 “W” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 110 "L" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 111 China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 112 "V" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 113 "U" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 114 “W” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 115 "L" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 116 India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 117 "V" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 118 "U" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 119 “W” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 120 "L" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 121 Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 122 "V" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 123 "U" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 124 “W” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 125 "L" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 126 Latin America Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 127 Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 128 “V” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 129 “U” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 130 “W” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 131 “L” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 132 Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 133 “V” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 134 “U” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 135 “W” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 136 “L” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 137 Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 138 "V" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 139 "U" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 140 “W” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 141 "L" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 142 Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 143 "V" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 144 "U" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 145 “W” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 146 "L" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 147 Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 148 "V" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 149 "U" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 150 “W” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 151 "L" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 152 Middle East and Africa Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 153 Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 154 “V” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 155 “U” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 156 “W” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 157 “L” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 158 Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 159 “V” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 160 “U” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 161 “W” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 162 “L” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 163 GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 164 "V" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 165 "U" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 166 “W” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 167 "L" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 168 South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 169 "V" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 170 "U" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 171 “W” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 172 "L" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 173 Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 174 "V" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 175 "U" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 176 “W” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 177 "L" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 178 Biodiem: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 179 CSL Limited: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 180 CSL Limited (Seqirus: Influenza Vaccine Division): Product Portfolio
Table 181 Emergent BioSolutions: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 182 Emergent BioSolutions: Product Portfolio
Table 183 AstraZeneca: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 184 Merck & Co., Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 185 Sanofi: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 186 Sanofi: Product Portfolio
Table 187 F. Hoffmann-La Roche Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 188 Sinovac Biotech Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 189 Mitsubishi Tanabe Pharma Corporation: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 190 Takeda Pharmaceutical Company Limited: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 191 Unmet Needs & Required Innovations
List of Figures
Figure 1 Global Influenza Vaccines Market Segmentation
Figure 2 Global Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR %)
Figure 3 Global Influenza Vaccines Market Share Forecast by Vaccine Type, 2020, 2025, 2030 (%)
Figure 4 Global Influenza Vaccines Market for Quadrivalent Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 5 “V” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 6 “U” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 7 “W” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 8 “L” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 9 Global Influenza Vaccines Market for Trivalent Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 10 “V” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 11 “U” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 12 “W” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 13 “L” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 14 Global Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR %)
Figure 15 Global Influenza Vaccines Market Share Forecast by End-Users, 2020, 2025, 2030 (%)
Figure 16 Global Influenza Vaccines Market for Hospitals Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 17 “V” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 18 “U” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 19 “W” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 20 “L” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 21 Global Influenza Vaccines Market for Specialty clinics segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 22 “V” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 23 “U” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 24 “W” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 25 “L” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 26 Global Influenza Vaccines Market for Other End-Users Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 27 “V” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 28 “U” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 29 “W” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 30 “L” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 31 Global Influenza Vaccines Market Forecast by Region 2020-2030 (US$ million)
Figure 32 Global Influenza Vaccines Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 33 North America Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 34 North America Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 35 North America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 36 North America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 37 U.S. Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 38 “V” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 39 “U” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 40 “W” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 41 “L” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 42 Canada Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 43 “V” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 44 “U” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 45 “W” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 46 “L” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 47 Europe Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 48 Europe Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 49 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 50 Europe Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 51 Germany Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 52 “V” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 53 “U” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 54 “W” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 55 “L” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 56 France Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 57 “V” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 58 “U” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 59 “W” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 60 “L” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 61 UK Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 62 “V” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 63 “U” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 64 “W” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 65 “L” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 66 Italy Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 67 “V” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 68 “U” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 69 “W” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 70 “L” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 71 Spain Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 72 “V” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 73 “U” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 74 “W” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 75 “L” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 76 Rest of Europe Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 77 “V” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 78 “U” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 79 “W” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 80 “L” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 81 Asia Pacific Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 82 Asia Pacific Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 83 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 84 Asia Pacific Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 85 Japan Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 86 “V” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 87 “U” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 88 “W” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 89 “L” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 90 China Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 91 “V” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 92 “U” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 93 “W” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 94 “L” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 95 India Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 96 “V” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 97 “U” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 98 “W” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 99 “L” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 100 Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 101 “V” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 102 “U” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 103 “W” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 104 “L” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 105 Latin America Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 106 Latin America Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 107 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 108 Latin America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 109 Brazil Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 110 “V” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 111 “U” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 112 “W” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 113 “L” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 114 Mexico Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 115 “V” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 116 “U” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 117 “W” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 118 “L” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 119 Rest of Latin America Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 120 “V” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 121 “U” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 122 “W” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 123 “L” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 124 Middle East and Africa Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 125 Middle East and Africa Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 126 Middle East and Africa Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 127 Middle East and Africa Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 128 GCC Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 129 “V” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 130 “U” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 131 “W” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 132 “L” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 133 South Africa Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 134 “V” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 135 “U” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 136 “W” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 137 “L” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 138 Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 139 “V” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 140 “U” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 141 “W” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 142 “L” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 143 Biodiem : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 144 CSL Limited : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 145 CSL Limited : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 146 Emergent BioSolutions : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 147 Emergent BioSolutions : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 148 Emergent BioSolutions : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 149 AstraZeneca : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 150 AstraZeneca : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 151 AstraZeneca : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 152 Merck & Co., Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 153 Merck & Co., Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 154 Merck & Co., Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 155 Sanofi : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 156 Sanofi : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 157 Sanofi : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 158 F. Hoffmann-La Roche Ltd. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 159 F. Hoffmann-La Roche Ltd. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 160 F. Hoffmann-La Roche Ltd. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 161 Sinovac Biotech Ltd. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 162 Sinovac Biotech Ltd. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 163 Sinovac Biotech Ltd. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 164 Mitsubishi Tanabe Pharma Corporation : Net Revenue, 2016-2018 (US$ Mn, AGR%)
Figure 165 Takeda Pharmaceutical Company Limited : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 166 Takeda Pharmaceutical Company Limited : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 167 Takeda Pharmaceutical Company Limited : Gross Profit, 2015-2019 (US$ Mn, AGR%)
1.1. Global Influenza Vaccines Market Segmentation
1.1 Why You Should Read This Report
1.2 What This Report Delivers
1.3 Key Questions Answered By This Analytical Report Include:
1.4 Who is This Report For?
1.5 Methodology
1.5.1 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQs)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2 Introduction
2.1 What is Influenza
2.2 Bird Flu
2.2.1 The avian influenza virus causes bird flu. Birds can be infected by influenza A viruses and all of its subtypes.
2.3 Annual Epidemics
2.3.1 Every year influenza causes 3-5 million cases of severe illness
2.4 Social & Economic Burden
2.4.1 An estimated $17 billion in the US alone is spent on direct medical costs and loss of labor on adults who have contracted influenza
3 Influenza Vaccine by Technology
3.1 Egg Based Flu Vaccine
3.1.1 The egg-based production system is used to make almost 500 million doses of flu vaccine every year.
3.2 Cell-Based Flu Vaccines
3.2.1 FDA issued an approval for Seqirus, the sole FDA-approved cell-based flu vaccine manufacturer in the United States, to use cell-grown CVVs.
3.3 Recombinant Flu Vaccines
3.3.1 This process can produce vaccine in the shortest amount of time
4 Executive Summary
4.1 Trivalent vaccine type anticipated to hold ~US$ 3.6 billion revenue in 2020
4.2 Quadrivalent to witness a CAGR of over 8%
4.3 Asia Pacific to witness the highest CAGR of over ~6%
5 Global Influenza Vaccines Market Overview
5.1 Drivers
5.1.1 Growing Elderly Population: Influenza vaccinations account for 50% of the demand for elderly people over 65 years
5.1.2 Growing Investments in Vaccine Development: Strong impetus for vaccine manufacturers to renew and/or expand research efforts
5.1.3 High Prevalence of Infectious Diseases: High prevalence of diseases, such as cholera, tuberculosis, hepatitis, and malaria will ensure strong demand for associated vaccines
5.1.4 Rising R&D Activities: Rising prevalence of infectious diseases and the growing focus on the immunization programs are considered as the major factors that are projected to enhance the growth
5.1.5 Increase in Government Focus on Immunization Programs: Broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs
5.1.6 Paediatric Influenza Vaccines: Paediatric influenza vaccines make up the second largest share of this vaccine industry
5.2 Restraints
5.2.1 Inadequate Reimbursement Coverage: National Immunization Survey found that 79% of privately insured children had some sort of payment associated with their last immunization visit.
5.2.2 Longer timelines required for Vaccine Production: Vaccine development is a long, complex process, often lasting 10-15 years
5.3 Opportunities
5.3.1 Rising Demand from Emerging Economies: China and India have already implemented the influenza vaccine into their immunization programmes
5.4 Market Trends
5.4.1 Demand Driven Trends: Developing economies are increasingly looking to improve their healthcare systems
5.4.2 Funding Trends: Despite the trend of increasing demand and supply in the future for the influenza vaccines market, funding is another factor that will affect the growth of the market
5.4.3 Protecting Workforce: Influenza results in hospitalization of up to 200,000 people each year. Such healthcare costs and burden have forced the governments to recognize the severity of influenza as a serious infection
5.5 SWOT Analysis
5.5.1 Strengths
5.5.1.1 Ageing Population
5.5.1.2 Influenza Prevention is Crucial
5.5.1.3 Growing Emerging Economies
5.5.1.4 Rising Disease Awareness
5.5.2 Weaknesses
5.5.2.1 Supply Chain Costs
5.5.2.2 Time Constraints
5.5.2.3 Barriers to Entry
5.5.2.4 Storage and Handling of Influenza Vaccines
5.5.3 Opportunities
5.5.3.1 Strong R&D Pipeline
5.5.3.2 Innovations and Technological Advancements
5.5.3.3 Universal Flu Vaccine
5.5.3.4 Adult Vaccines
5.5.4 Threats
5.5.4.1 Productivity Gap
5.6 PEST Analysis
5.6.1 Political Factors
5.6.1.1 Influence of Governments: The economic issues are very closely linked to the political issues that could influence the influenza vaccines market
5.6.2 Economic Factors
5.6.2.1 Cost & Time: Cost is a big factor in most things, and the influenza vaccines industry is no exception
5.6.2.2 Emerging Economies: High needs for preventive medicine across emerging economies to boost market growth
5.6.3 Social Factors
5.6.3.1 Creating a Healthier Society: One of the biggest social factors of the influenza vaccines industry would be the obvious benefits to healthcare that they bring
5.6.3.2 Public Fears of Side-Effects: On the flip side of the health benefits that vaccines bring, we can see slight resistance to vaccines from some
5.6.4 Technological Factors
5.6.4.1 Advancements in Vaccine Technology: Advancements being made in the influenza vaccine development will play a part in the future of the business
5.7 R&D Landscape Analysis
5.7.1 Fluzone® QIV HD: Fluzone High-Dose Quadrivalent is approved for use in persons 65 years of age and older.
5.7.2 AFLURIA® Quad (Quadrivalent Egg-based Influenza Vaccine): Afluria Quad™ is an inactivated quadrivalent influenza vaccine indicated for use in adults aged 18 years and over.
5.7.3 FLUCELVAX®: FLUCELVAX QUADRIVALENT is approved for use in persons 4 years of age and older.
5.7.4 FLUAD®: FLUAD is approved in over 30 countries; and to date, more than 81 million FLUAD doses have been distributed worldwide.
5.7.5 UNI-FLU: This candidate is a nanoparticle vaccine that self-assembles during production and that displays a cross-reactive antigen for each broad influenza group
5.7.6 NanoFlu™
6 Market Comparison Developed V.S. Emerging Economies
6.1 Developed Economies
6.2 Emerging Economies
6.3 Influenza Vaccine Situation Across LMIC Region
6.3.1 Egypt: Vaccination coverage remains low in Egypt
6.3.2 Lebanon: Uptake of the vaccines is improving; it is still a long way to achieve full coverage of high-risk vaccines.
6.3.3 Saudi Arabia: There have also been several public awareness campaigns the flu vaccine is administered and funded by MoH.
7 Global Influenza Vaccines Market Size Forecast 2020-2030 by Vaccine Type
7.1 Global Influenza Vaccines Market for Quadrivalent Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.1.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2 Global Influenza Vaccines Market for Trivalent Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
7.2.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8 Global Influenza Vaccines Market Size Forecast 2020-2030 by End-Users
8.1 Global Influenza Vaccines Market for Hospitals Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.1.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2 Global Influenza Vaccines Market for Specialty clinics segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.2.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Specialty Clinics Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3 Global Influenza Vaccines Market for Other End-Users Segment: Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.1 “V” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.2 “U” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.3 “W” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
8.3.4 “L” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Revenue Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9 Regional and Leading National Influenza Vaccines Market Forecasts 2020-2030
9.1 Global Influenza Vaccines Market by National Market Forecast 2020-2030
9.1.1 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.2 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.3 "W" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
9.1.4 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
10 North America
10.1 North America Influenza Vaccines Market by Country Forecast 2020-2030
10.2 North America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
10.2.1 Recovery Scenarios (V, U, W, L): North America Influenza Vaccines Market by Vaccine Type
10.3 North America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
10.3.1 Recovery Scenarios (V, U, W, L): North America Influenza Vaccines Market by End-Users
10.4 U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.1 Obama Healthcare Reform – the Benefits for Vaccine Sales
10.4.2 In the US Influenza Vaccines Come Equally from Manufacturers and Distributors
10.4.3 “V” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.4 “U” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.5 “W” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.4.6 “L” Shaped Recovery Scenario: U.S. Influenza Vaccines Market Forecast 2020-2030
10.5 Canada Influenza Vaccines Market Forecast 2020-2030
10.5.1 High Burden Among Children Population
10.5.2 Vaccine Products Available for Use in Canada
10.5.3 “V” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.4 “U” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.5 “W” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
10.5.6 “L” Shaped Recovery Scenario: Canada Influenza Vaccines Market Forecast 2020-2030
11 Europe
11.1 Europe Influenza Vaccines Market by Country Forecast 2020-2030
11.2 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
11.2.1 Recovery Scenarios (V, U, W, L): Europe Influenza Vaccines Market by Vaccine Type
11.3 Europe Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
11.3.1 Recovery Scenarios (V, U, W, L): Europe Influenza Vaccines Market by End-Users
11.4 Germany Influenza Vaccines Market Forecast 2020-2030
11.4.1 Economic Downturn and Ripple Effect
11.4.2 “V” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.3 “U” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.4 “W” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.4.5 “L” Shaped Recovery Scenario: Germany Influenza Vaccines Market Forecast 2020-2030
11.5 France Influenza Vaccines Market Forecast 2020-2030
11.5.1 Prominent Market
11.5.2 French Healthcare System
11.5.3 Doubt over Vaccine Safety Among French Population
11.5.4 “V” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.5 “U” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.6 “W” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.5.7 “L” Shaped Recovery Scenario: France Influenza Vaccines Market Forecast 2020-2030
11.6 UK Influenza Vaccines Market Forecast 2020-2030
11.6.1 Mature Market
11.6.2 “V” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.3 “U” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.4 “W” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.6.5 “L” Shaped Recovery Scenario: UK Influenza Vaccines Market Forecast 2020-2030
11.7 Italy Influenza Vaccines Market Forecast 2020-2030
11.7.1 Economic Climate
11.7.2 Challenges in Public Healthcare
11.7.3 “V” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.4 “U” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.5 “W” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.7.6 “L” Shaped Recovery Scenario: Italy Influenza Vaccines Market Forecast 2020-2030
11.8 Spain Influenza Vaccines Market Forecast 2020-2030
11.8.1 Ageing Population
11.8.2 Economic Challenges
11.8.3 “V” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.4 “U” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.5 “W” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.8.6 “L” Shaped Recovery Scenario: Spain Influenza Vaccines Market Forecast 2020-2030
11.9 Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.1 “V” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.2 “U” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.3 “W” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
11.9.4 “L” Shaped Recovery Scenario: Rest of Europe Influenza Vaccines Market Forecast 2020-2030
12 Asia Pacific
12.1 Asia Pacific Influenza Vaccines Market by Country Forecast 2020-2030
12.2 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
12.2.1 Recovery Scenarios (V, U, W, L): Asia Pacific Influenza Vaccines Market by Vaccine Type
12.3 Asia Pacific Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
12.3.1 Recovery Scenarios (V, U, W, L): Asia Pacific Influenza Vaccines Market by End-Users
12.4 Japan Influenza Vaccines Market Forecast 2020-2030
12.4.1 Challenging Market
12.4.2 Vaccine Gap to Offer Immense Growth Opportunities
12.4.3 “V” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.4 “U” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.5 “W” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.4.6 “L” Shaped Recovery Scenario: Japan Influenza Vaccines Market Forecast 2020-2030
12.5 China Influenza Vaccines Market Forecast 2020-2030
12.5.1 Growing Population
12.5.2 Growing National Demand
12.5.3 Low Confidence Towards Domestic Vaccine
12.5.4 Voluntarily Spending by Chinese Population
12.5.5 “V” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.6 “U” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.7 “W” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.5.8 “L” Shaped Recovery Scenario: China Influenza Vaccines Market Forecast 2020-2030
12.6 India Influenza Vaccines Market Forecast 2020-2030
12.6.1 Emerging Market
12.6.2 “V” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.3 “U” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.4 “W” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.6.5 “L” Shaped Recovery Scenario: India Influenza Vaccines Market Forecast 2020-2030
12.7 Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.1 “V” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.2 “U” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.3 “W” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
12.7.4 “L” Shaped Recovery Scenario: Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030
13 Latin America
13.1 Latin America Influenza Vaccines Market by Country Forecast 2020-2030
13.2 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
13.2.1 Recovery Scenarios (V, U, W, L): Latin America Influenza Vaccines Market by Vaccine Type
13.3 Latin America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
13.3.1 Recovery Scenarios (V, U, W, L): Latin America Influenza Vaccines Market by End-Users
13.4 Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.1 “V” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.2 “U” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.3 “W” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.4.4 “L” Shaped Recovery Scenario: Brazil Influenza Vaccines Market Forecast 2020-2030
13.5 Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.1 “V” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.2 “U” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.3 “W” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.5.4 “L” Shaped Recovery Scenario: Mexico Influenza Vaccines Market Forecast 2020-2030
13.6 Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.1 “V” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.2 “U” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.3 “W” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
13.6.4 “L” Shaped Recovery Scenario: Rest of Latin America Influenza Vaccines Market Forecast 2020-2030
14 Middle East and Africa
14.1 Middle East and Africa Influenza Vaccines Market by Country Forecast 2020-2030
14.2 Middle East and Africa Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
14.2.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Influenza Vaccines Market by Vaccine Type
14.3 Middle East and Africa Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
14.3.1 Recovery Scenarios (V, U, W, L): Middle East and Africa Influenza Vaccines Market by End-Users
14.4 GCC Influenza Vaccines Market Forecast 2020-2030
14.4.1 “V” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.2 “U” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.3 “W” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.4.4 “L” Shaped Recovery Scenario: GCC Influenza Vaccines Market Forecast 2020-2030
14.5 South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.1 “V” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.2 “U” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.3 “W” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.5.4 “L” Shaped Recovery Scenario: South Africa Influenza Vaccines Market Forecast 2020-2030
14.6 Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.1 “V” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.2 “U” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.3 “W” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
14.6.4 “L” Shaped Recovery Scenario: Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030
15 Company Profiling
15.1 Biodiem
15.1.1 Biodiem: Company Snapshot
15.1.2 Biodiem: Company Overview
15.1.3 Biodiem: Financial Analysis
15.1.3.1 Net Revenue, 2015-2019
15.1.4 Biodiem: Products
15.1.5 Biodiem: Recent Developments
15.2 CSL Limited
15.2.1 CSL Limited: Company Snapshot
15.2.2 CSL Limited: Company Overview
15.2.3 CSL Limited: Financial Analysis
15.2.3.1 Net Revenue, 2015-2019
15.2.3.2 Gross Profit, 2015-2019
15.2.4 CSL Limited: Products
15.2.5 CSL Limited: Recent Developments
15.3 Emergent BioSolutions
15.3.1 Emergent BioSolutions: Company Snapshot
15.3.2 Emergent BioSolutions: Company Overview
15.3.3 Emergent BioSolutions: Financial Analysis
15.3.3.1 Net Revenue, 2015-2019
15.3.3.2 EBIDTA, 2015-2019
15.3.3.3 Gross Profit, 2015-2019
15.3.4 Emergent BioSolutions: Products
15.3.5 Emergent BioSolutions: Recent Developments
15.4 AstraZeneca
15.4.1 AstraZeneca: Company Snapshot
15.4.2 AstraZeneca: Company Overview
15.4.3 AstraZeneca: Financial Analysis
15.4.3.1 Net Revenue, 2015-2019
15.4.3.2 EBIDTA, 2015-2019
15.4.3.3 Gross Profit, 2015-2019
15.5 Merck & Co., Inc.
15.5.1 Merck & Co., Inc.: Company Snapshot
15.5.2 Merck & Co., Inc.: Company Overview
15.5.3 Merck & Co., Inc.: Financial Analysis
15.5.3.1 Net Revenue, 2015-2019
15.5.3.2 EBIDTA, 2015-2019
15.5.3.3 Gross Profit, 2015-2019
15.5.4 Merck & Co., Inc.: Recent Developments
15.6 Sanofi
15.6.1 Sanofi: Company Snapshot
15.6.2 Sanofi: Company Overview
15.6.3 Sanofi: Financial Analysis
15.6.3.1 Net Revenue, 2015-2019
15.6.3.2 EBIDTA, 2015-2019
15.6.3.3 Gross Profit, 2015-2019
15.6.4 Sanofi: Products
15.6.5 Sanofi: Recent Developments
15.7 F. Hoffmann-La Roche Ltd.
15.7.1 F. Hoffmann-La Roche Ltd.: Company Snapshot
15.7.2 F. Hoffmann-La Roche Ltd.: Company Overview
15.7.3 F. Hoffmann-La Roche Ltd.: Financial Analysis
15.7.3.1 Net Revenue, 2015-2019
15.7.3.2 EBIDTA, 2015-2019
15.7.3.3 Gross Profit, 2015-2019
15.7.4 F. Hoffmann-La Roche Ltd.: Recent Developments
15.8 Sinovac Biotech Ltd.
15.8.1 Sinovac Biotech Ltd.: Company Snapshot
15.8.2 Sinovac Biotech Ltd.: Company Overview
15.8.3 Sinovac Biotech Ltd.: Financial Analysis
15.8.3.1 Net Revenue, 2015-2019
15.8.3.2 EBIDTA, 2015-2019
15.8.3.3 Gross Profit, 2015-2019
15.8.4 Sinovac Biotech Ltd.: Recent Developments
15.9 Mitsubishi Tanabe Pharma Corporation
15.9.1 Mitsubishi Tanabe Pharma Corporation: Company Snapshot
15.9.2 Mitsubishi Tanabe Pharma Corporation: Company Overview
15.9.3 Mitsubishi Tanabe Pharma Corporation: Financial Analysis
15.9.3.1 Net Revenue, 2016-2018
15.9.4 Mitsubishi Tanabe Pharma Corporation: Recent Developments
15.10 Takeda Pharmaceutical Company Limited
15.10.1 Takeda Pharmaceutical Company Limited: Company Snapshot
15.10.2 Takeda Pharmaceutical Company Limited: Company Overview
15.10.3 Takeda Pharmaceutical Company Limited: Financial Analysis
15.10.3.1 Net Revenue, 2015-2019
15.10.3.2 EBIDTA, 2015-2019
15.10.3.3 Gross Profit, 2015-2019
16 Conclusion & Recommendations
16.1 Concluding Remarks
16.2 Prevention of Influenza by Use of Flu Shots Rises in Importance
16.3 Emergence of a Universal Flu Vaccine
16.4 Unique & Complex Market
16.5 Unmet Needs & Required Innovations
List of Tables
Table 1 Global Influenza Vaccines Market Snapshot, 2020 & 2030 (US$ million, CAGR %)
Table 2 Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 3 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 4 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 5 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 6 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Quadrivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 7 Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 8 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 9 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 10 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 11 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Trivalent Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 12 Global Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 13 Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 14 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 15 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 16 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 17 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Hospitals Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 18 Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 19 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 20 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 21 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 22 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Specialty clinics segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 23 Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 24 "V" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 25 "U" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 26 “W” Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 27 "L" Shaped Recovery: Global Influenza Vaccines Market Forecast for Other End-Users Segment, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 28 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 29 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 30 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 31 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 32 Global Influenza Vaccines Market by Region Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 33 North America Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 34 North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 35 “V” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 36 “U” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 37 “W” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 38 “L” Shaped Recovery: North America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 39 North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 40 “V” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 41 “U” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 42 “W” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 43 “L” Shaped Recovery: North America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 44 U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 45 "V" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 46 "U" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 47 “W” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 48 "L" Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 49 Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 50 "V" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 51 "U" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 52 “W” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 53 "L" Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 54 Europe Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 55 Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 56 “V” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 57 “U” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 58 “W” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 59 “L” Shaped Recovery: Europe Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 60 Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 61 “V” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 62 “U” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 63 “W” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 64 “L” Shaped Recovery: Europe Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 65 Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 66 "V" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 67 "U" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 68 “W” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 69 "L" Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 70 France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 71 "V" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 72 "U" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 73 “W” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 74 "L" Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 75 UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 76 "V" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 77 "U" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 78 “W” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 79 "L" Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 80 Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 81 "V" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 82 "U" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 83 “W” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 84 "L" Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 85 Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 86 "V" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 87 "U" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 88 “W” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 89 "L" Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 90 Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 91 "V" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 92 "U" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 93 “W” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 94 "L" Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 95 Asia Pacific Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 96 Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 97 “V” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 98 “U” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 99 “W” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 100 “L” Shaped Recovery: Asia Pacific Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 101 Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 102 “V” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 103 “U” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 104 “W” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 105 “L” Shaped Recovery: Asia Pacific Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 106 Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 107 "V" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 108 "U" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 109 “W” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 110 "L" Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 111 China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 112 "V" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 113 "U" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 114 “W” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 115 "L" Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 116 India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 117 "V" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 118 "U" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 119 “W” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 120 "L" Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 121 Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 122 "V" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 123 "U" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 124 “W” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 125 "L" Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 126 Latin America Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 127 Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 128 “V” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 129 “U” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 130 “W” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 131 “L” Shaped Recovery: Latin America Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 132 Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 133 “V” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 134 “U” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 135 “W” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 136 “L” Shaped Recovery: Latin America Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 137 Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 138 "V" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 139 "U" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 140 “W” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 141 "L" Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 142 Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 143 "V" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 144 "U" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 145 “W” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 146 "L" Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 147 Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 148 "V" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 149 "U" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 150 “W” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 151 "L" Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 152 Middle East and Africa Influenza Vaccines Market by Country Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 153 Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 154 “V” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 155 “U” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 156 “W” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 157 “L” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by Vaccine Type Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 158 Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 159 “V” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 160 “U” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 161 “W” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 162 “L” Shaped Recovery: Middle East and Africa Influenza Vaccines Market by End-Users Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 163 GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 164 "V" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 165 "U" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 166 “W” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 167 "L" Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 168 South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 169 "V" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 170 "U" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 171 “W” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 172 "L" Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 173 Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 174 "V" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 175 "U" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 176 “W” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 177 "L" Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ Mn, AGR%, CAGR%)
Table 178 Biodiem: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 179 CSL Limited: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 180 CSL Limited (Seqirus: Influenza Vaccine Division): Product Portfolio
Table 181 Emergent BioSolutions: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 182 Emergent BioSolutions: Product Portfolio
Table 183 AstraZeneca: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 184 Merck & Co., Inc.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 185 Sanofi: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 186 Sanofi: Product Portfolio
Table 187 F. Hoffmann-La Roche Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 188 Sinovac Biotech Ltd.: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 189 Mitsubishi Tanabe Pharma Corporation: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 190 Takeda Pharmaceutical Company Limited: Key Details, 2020 (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 191 Unmet Needs & Required Innovations
List of Figures
Figure 1 Global Influenza Vaccines Market Segmentation
Figure 2 Global Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR %)
Figure 3 Global Influenza Vaccines Market Share Forecast by Vaccine Type, 2020, 2025, 2030 (%)
Figure 4 Global Influenza Vaccines Market for Quadrivalent Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 5 “V” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 6 “U” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 7 “W” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 8 “L” Shaped Recovery: Global Influenza Vaccines Market for Quadrivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 9 Global Influenza Vaccines Market for Trivalent Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 10 “V” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 11 “U” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 12 “W” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 13 “L” Shaped Recovery: Global Influenza Vaccines Market for Trivalent Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 14 Global Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR %)
Figure 15 Global Influenza Vaccines Market Share Forecast by End-Users, 2020, 2025, 2030 (%)
Figure 16 Global Influenza Vaccines Market for Hospitals Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 17 “V” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 18 “U” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 19 “W” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 20 “L” Shaped Recovery: Global Influenza Vaccines Market for Hospitals Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 21 Global Influenza Vaccines Market for Specialty clinics segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 22 “V” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 23 “U” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 24 “W” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 25 “L” Shaped Recovery: Global Influenza Vaccines Market for Specialty clinics segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 26 Global Influenza Vaccines Market for Other End-Users Segment: Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 27 “V” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 28 “U” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 29 “W” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 30 “L” Shaped Recovery: Global Influenza Vaccines Market for Other End-Users Segment, Revenue Forecast 2020-2030 (US$ million, AGR%)
Figure 31 Global Influenza Vaccines Market Forecast by Region 2020-2030 (US$ million)
Figure 32 Global Influenza Vaccines Market Share Forecast by Region 2020, 2025, 2030 (%)
Figure 33 North America Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 34 North America Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 35 North America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 36 North America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 37 U.S. Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 38 “V” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 39 “U” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 40 “W” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 41 “L” Shaped Recovery: U.S. Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 42 Canada Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 43 “V” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 44 “U” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 45 “W” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 46 “L” Shaped Recovery: Canada Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 47 Europe Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 48 Europe Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 49 Europe Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 50 Europe Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 51 Germany Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 52 “V” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 53 “U” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 54 “W” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 55 “L” Shaped Recovery: Germany Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 56 France Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 57 “V” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 58 “U” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 59 “W” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 60 “L” Shaped Recovery: France Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 61 UK Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 62 “V” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 63 “U” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 64 “W” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 65 “L” Shaped Recovery: UK Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 66 Italy Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 67 “V” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 68 “U” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 69 “W” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 70 “L” Shaped Recovery: Italy Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 71 Spain Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 72 “V” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 73 “U” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 74 “W” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 75 “L” Shaped Recovery: Spain Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 76 Rest of Europe Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 77 “V” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 78 “U” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 79 “W” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 80 “L” Shaped Recovery: Rest of Europe Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 81 Asia Pacific Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 82 Asia Pacific Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 83 Asia Pacific Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 84 Asia Pacific Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 85 Japan Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 86 “V” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 87 “U” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 88 “W” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 89 “L” Shaped Recovery: Japan Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 90 China Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 91 “V” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 92 “U” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 93 “W” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 94 “L” Shaped Recovery: China Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 95 India Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 96 “V” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 97 “U” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 98 “W” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 99 “L” Shaped Recovery: India Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 100 Rest of Asia Pacific Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 101 “V” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 102 “U” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 103 “W” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 104 “L” Shaped Recovery: Rest of Asia Pacific Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 105 Latin America Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 106 Latin America Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 107 Latin America Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 108 Latin America Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 109 Brazil Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 110 “V” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 111 “U” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 112 “W” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 113 “L” Shaped Recovery: Brazil Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 114 Mexico Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 115 “V” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 116 “U” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 117 “W” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 118 “L” Shaped Recovery: Mexico Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 119 Rest of Latin America Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 120 “V” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 121 “U” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 122 “W” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 123 “L” Shaped Recovery: Rest of Latin America Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 124 Middle East and Africa Influenza Vaccines Market Forecast by Country 2020-2030 (US$ million)
Figure 125 Middle East and Africa Influenza Vaccines Market Share Forecast by Country 2020, 2025, 2030 (%)
Figure 126 Middle East and Africa Influenza Vaccines Market Forecast by Vaccine Type, 2020-2030 (US$ million, AGR%)
Figure 127 Middle East and Africa Influenza Vaccines Market Forecast by End-Users, 2020-2030 (US$ million, AGR%)
Figure 128 GCC Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 129 “V” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 130 “U” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 131 “W” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 132 “L” Shaped Recovery: GCC Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 133 South Africa Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 134 “V” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 135 “U” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 136 “W” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 137 “L” Shaped Recovery: South Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 138 Rest of Middle East and Africa Influenza Vaccines Market Forecast 2020-2030 (US$ million, AGR %)
Figure 139 “V” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 140 “U” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 141 “W” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 142 “L” Shaped Recovery: Rest of Middle East and Africa Influenza Vaccines Market Forecast, 2020-2030 (US$ million, AGR%)
Figure 143 Biodiem : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 144 CSL Limited : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 145 CSL Limited : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 146 Emergent BioSolutions : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 147 Emergent BioSolutions : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 148 Emergent BioSolutions : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 149 AstraZeneca : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 150 AstraZeneca : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 151 AstraZeneca : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 152 Merck & Co., Inc. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 153 Merck & Co., Inc. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 154 Merck & Co., Inc. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 155 Sanofi : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 156 Sanofi : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 157 Sanofi : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 158 F. Hoffmann-La Roche Ltd. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 159 F. Hoffmann-La Roche Ltd. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 160 F. Hoffmann-La Roche Ltd. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 161 Sinovac Biotech Ltd. : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 162 Sinovac Biotech Ltd. : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 163 Sinovac Biotech Ltd. : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Figure 164 Mitsubishi Tanabe Pharma Corporation : Net Revenue, 2016-2018 (US$ Mn, AGR%)
Figure 165 Takeda Pharmaceutical Company Limited : Net Revenue, 2015-2019 (US$ Mn, AGR%)
Figure 166 Takeda Pharmaceutical Company Limited : EBIDTA, 2015-2019 (US$ Mn, AGR%)
Figure 167 Takeda Pharmaceutical Company Limited : Gross Profit, 2015-2019 (US$ Mn, AGR%)
Companies Profiled in the Report
AstraZeneca
Biodiem
CSL Limited
Emergent BioSolutions
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Novartis AG
Sanofi
Sinovac Biotech Ltd.
Takeda Pharmaceutical Company Limited
List of Other Companies
Astellas Pharmaceuticals
Bharat Immunologicals and Biologicals Corporation Limited
Binnopharm
Bio Farma
bioCSL
BiondVax
Bionor
Biremx
Dynavax
Krka Pharmaceuticals
MSD Pharmaceuticals
Serum Institute of India (SLL)
Shionogi Pharmaceuticals
Sinopharm
SmithKline Beecham
Vacsera
VaxInnate
VaxInnate Corporation
List of Organizations
Advisory Committee for Immunization Practices
Brazilian Ministry of Health
Butantan Institute
Cabtacuzino Institute
Center for Biologics Evaluation and Research
Centers for Disease Control and Prevention (CDC)
Centre for Disease Control and Prevention
Chemo-Sero-Therapeutic Research Institute
China National Biotech Group
China’s National Regulatory Authority
Chinese Food and Drug Administration
ClearPath
CureVac
Medicago
Medicines and Healthcare products Regulatory Agency (MHRA)
MedImmune
Protein Science Corporation
Razi Institute
The Ministry of Health, Labour and Welfare, Japan
The Scripps Research Institute
Torlak Institut
Ultriks
US Department of Health and Human Services
WHO Strategic Advisory Group of Experts
World Health Organization
AstraZeneca
Biodiem
CSL Limited
Emergent BioSolutions
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Mitsubishi Tanabe Pharma Corporation
Novartis AG
Sanofi
Sinovac Biotech Ltd.
Takeda Pharmaceutical Company Limited
List of Other Companies
Astellas Pharmaceuticals
Bharat Immunologicals and Biologicals Corporation Limited
Binnopharm
Bio Farma
bioCSL
BiondVax
Bionor
Biremx
Dynavax
Krka Pharmaceuticals
MSD Pharmaceuticals
Serum Institute of India (SLL)
Shionogi Pharmaceuticals
Sinopharm
SmithKline Beecham
Vacsera
VaxInnate
VaxInnate Corporation
List of Organizations
Advisory Committee for Immunization Practices
Brazilian Ministry of Health
Butantan Institute
Cabtacuzino Institute
Center for Biologics Evaluation and Research
Centers for Disease Control and Prevention (CDC)
Centre for Disease Control and Prevention
Chemo-Sero-Therapeutic Research Institute
China National Biotech Group
China’s National Regulatory Authority
Chinese Food and Drug Administration
ClearPath
CureVac
Medicago
Medicines and Healthcare products Regulatory Agency (MHRA)
MedImmune
Protein Science Corporation
Razi Institute
The Ministry of Health, Labour and Welfare, Japan
The Scripps Research Institute
Torlak Institut
Ultriks
US Department of Health and Human Services
WHO Strategic Advisory Group of Experts
World Health Organization
Download sample pages
Complete the form below to download your free sample pages for Influenza Vaccines Market Report 2020-2030Related reports
Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are...Full DetailsPublished: 04 March 2021Protein Engineering Market Report 2021-2031
Growing investment in drug R&D by pharmaceutical and biopharmaceutical companies; investment by government for novel vaccine development for COVID-19; rising...Full DetailsPublished: 11 February 20213D Cell Culture and 3D Bioprinting Market Report 2022-2032
The 3D cell culture market is experiencing impressive growth globally because of the tremendous increase in demand for biopharmaceutical products....Full DetailsPublished: 15 February 2022Asia Vaccines Market Forecast to 2029
Asia vaccines market is estimated at $7bn in 2018 and is expected to grow at a CAGR of 8.8% during...
Full DetailsPublished: 28 October 2019Stem Cell Technologies and Applications Market Report 2021-2031
Factors such as rising prevalence of chronic and genetic diseases, increasing application areas of stem cell technologies, technological advancements, and...Full DetailsPublished: 10 August 2021Cellular Immunotherapy Market Report 2021-2031
Increasing prevalence of cancers and rising demand for advanced therapies for cancer treatment are the major factors driving the demand...Full DetailsPublished: 08 June 2021Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand...Full DetailsPublished: 13 July 2021Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2020-2030
Overall world revenue for CMO of sterile injectable drugs will surpass US$55.33 billion by 2030, our work calculates. We predict...
Full DetailsPublished: 01 May 2020Contract Manufacturing Outsourcing (CMO) of Sterile Injectable Drugs Market Report 2021-2031
Contract manufacturing outsourcing is gaining attraction owing to growing trend of outsourcing among pharmaceutical businesses. ...Full DetailsPublished: 16 November 2021Top 25 Vaccines Market Forecast to 2029
Visiongain expects market growth from $25.19bn in 2018 to $40.80bn in 2024, growing at a CAGR of 8.42%. The developing...
Full DetailsPublished: 27 February 2020
Download sample pages
Complete the form below to download your free sample pages for Influenza Vaccines Market Report 2020-2030Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Allergy Immunotherapy Market Report 2023-2033
The global Allergy Immunotherapy market is projected to grow at a CAGR of 7.6% by 2033
31 May 2023
Visiongain Publishes AI-based Clinical Trial Solution Providers Market Report 2023-2033
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
26 May 2023
Visiongain Publishes Vaccine Contract Manufacturing Market Report 2023-2033
The global Vaccine Contract Manufacturing Market is projected to grow at a CAGR of 13.2% by 2033
24 May 2023
Visiongain Publishes Cell & Gene Therapy Cold Chain Logistics Market Report 2023-2033
The global Cell & Gene Therapy Cold Chain Logistics market is projected to grow at a CAGR of 15% by 2033
23 May 2023
